Onconetix Inc (ONCO NASDAQ) stock market data APIs
$4.2949
0.33(7.7%)
as of July 7, 2025
Try our APIs with
free plan!
Onconetix Inc Financial Data Overview
Price chart is built with
Anychart
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Prev. Close
4.2949
Open
4.6227
High
4.6227
Low
4.0929
52 wk Range
3.82-741.2
Market Cap
2 427 K
Shares Outstanding
522 K
Revenue
1 925 K
EPS
-45.44
Beta
3.509
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Onconetix Inc data using free add-ons & libraries
Get Onconetix Inc Fundamental Data
Onconetix Inc Fundamental data includes:
- Net Revenue: 1 925 K
- EBITDA: -5 658 265
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Onconetix Inc News
New
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
CINCINNATI, Ohio, June 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, developm...
Onconetix announces 1-for-85 reverse stock split
* Onconetix (NASDAQ:ONCO [https://seekingalpha.com/symbol/ONCO]) on Wednesday said the company’s stockholders have approved a proposal to effect a 1-for-85 reverse split. * The company’s commo...
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, developm...
Onconetix receives additional delisting notice from Nasdaq
Onconetix (ONCO) received a staff delisting letter from Nasdaq on May 20 indicating that the company’s failure to file its Quarterly Report Q for the three months ended March 31, 2025 is in violatio...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
